Advantages of Clinical- Stage GlycoConnectTM Platform Technology – Successful Application for Multiple Targets & With Different Payload Classes
Time: 4:30 pm
day: Scientific Program Day Two PM
Details:
- GlycoConnectTM, HydraSpace® and toxSYN® technologies enable ADCs with best-in-class therapeutic index potential
- Updates on the rapidly advancing pipeline of GlycoConnectTM ADCs by partners
- Clinical development insights on the most advanced assets
